The prognostic significant of percentage drop in serum CEA post curative resection for colon cancer

被引:29
作者
Lee, Won-Suk [1 ]
Baek, Jeong-Heum [1 ]
Kim, Keon Kuk [1 ]
Park, Yeon Ho [1 ]
机构
[1] Gachon Univ Med & Sci, Dept Surg, Gil Med Ctr, Inchon 405760, South Korea
来源
SURGICAL ONCOLOGY-OXFORD | 2012年 / 21卷 / 01期
关键词
Colon neoplasm; Survival; CEA; CARCINOEMBRYONIC ANTIGEN LEVEL; COLORECTAL-CANCER; RECTAL-CANCER; ADJUVANT THERAPY; FOLLOW-UP; RECURRENCE; SURVIVAL; FLUOROURACIL; CHEMOTHERAPY; CARCINOMA;
D O I
10.1016/j.suronc.2010.10.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective/background: This study aimed to analyze the hypothesis that increased percentage drop in serum CEA post curative resection for colon cancer is associated with improved survival. Methods: Five hundred thirty three patients who underwent colon resection with a curative intent were retrospectively analyzed for their pre- and postoperative CEA levels. The disease-free and overall survival curves were calculated using Kaplan Meier analysis to evaluate cancer related outcomes. For multivariate analysis, the Cox regression model was used. Results: The estimated 5-year overall survival for the preoperative serum CEA > 5 ng/mL group with respect to a postoperative CEA level drop rate of 40%, 50% and 60% were 72.9%, 80.9% and 81.8%, respectively. The estimated 5-year overall survival for the preoperative serum CEA <= 5 ng/mL group with respect to each postoperative CEA level drop rate were 86.6%, 97.1% and 97.7%, respectively (P = 0.257, P = 0.092 and P = 0.073, respectively). The prognostic factors for poor survival were the depth of invasion (p = 0.042, hazard ratio: 2.617, 95% CI = 1.021-3.012) and lymph node metastasis (p = 0.008, hazard ratio: 2.249, 95% CI = 1.231-4.111). A 60% drop of the CEA level was an independent prognostic factor for survival (p = 0.001, hazard ratio: 2.954, 95% CI = 1.686-5.176) for patients with a preoperative CEA level > 5 ng/mL. Conclusion: Determining the preoperative CEA level and the early postoperative percent drop of the serum CEA level may be a helpful factor for the prognosis of colon caner patients. However, the percent drop from the pre to postoperative CEA level from the normal range was not associated with survival difference. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:45 / 51
页数:7
相关论文
共 37 条
[1]  
Ahnen DJ, 1998, CANCER RES, V58, P1149
[2]   Kirsten ras mutations in patients with colorectal cancer:: the 'RASCAL II' study [J].
Andreyev, HJN ;
Norman, AR ;
Cunningham, D ;
Oates, J ;
Dix, BR ;
Iacopetta, BJ ;
Young, J ;
Walsh, T ;
Ward, R ;
Hawkins, N ;
Beranek, M ;
Jandik, P ;
Benamouzig, R ;
Jullian, E ;
Laurent-Puig, P ;
Olschwang, S ;
Muller, O ;
Hoffmann, I ;
Rabes, HM ;
Zietz, C ;
Troungos, C ;
Valavanis, C ;
Yuen, ST ;
Ho, JWC ;
Croke, CT ;
O'Donoghue, DP ;
Giaretti, W ;
Rapallo, A ;
Russo, A ;
Bazan, V ;
Tanaka, M ;
Omura, K ;
Azuma, T ;
Ohkusa, T ;
Fujimori, T ;
Ono, Y ;
Pauly, M ;
Faber, C ;
Glaesener, R ;
de Goeij, AFPM ;
Arends, JW ;
Andersen, SN ;
Lövig, T ;
Breivik, J ;
Gaudernack, G ;
Clausen, OPF ;
De Angelis, P ;
Meling, GI ;
Rognum, TO ;
Smith, R .
BRITISH JOURNAL OF CANCER, 2001, 85 (05) :692-696
[3]  
Behr TM, 1996, CANCER RES, V56, P1805
[4]   FOLLOW-UP OF PATIENTS WITH COLORECTAL-CANCER - A METAANALYSIS [J].
BRUINVELS, DJ ;
STIGGELBOUT, AM ;
KIEVIT, J ;
VANHOUWELINGEN, HC ;
HABBEMA, JDF ;
VANDEVELDE, CJH .
ANNALS OF SURGERY, 1994, 219 (02) :174-182
[5]   Should carcinoembryonic antigen be used in the management of patients with colorectal cancer? [J].
Carriquiry, LA ;
Piñeyro, A .
DISEASES OF THE COLON & RECTUM, 1999, 42 (07) :921-929
[6]   Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer? [J].
Chen, CC ;
Yang, SH ;
Lin, JK ;
Lin, TC ;
Chen, WS ;
Jiang, JK ;
Wang, HS ;
Chang, SC .
JOURNAL OF SURGICAL RESEARCH, 2005, 124 (02) :169-174
[7]  
Compton CC, 2000, ARCH PATHOL LAB MED, V124, P979
[8]   SPECIFIC CARCINOEMBRYONIC ANTIGENS OF HUMAN DIGESTIVE SYSTEM [J].
GOLD, P ;
FREEDMAN, SO .
JOURNAL OF EXPERIMENTAL MEDICINE, 1965, 122 (03) :467-&
[9]   Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer [J].
Goldstein, MJ ;
Mitchell, EP .
CANCER INVESTIGATION, 2005, 23 (04) :338-351
[10]  
Greene F., 2002, AJCC cancer staging handbook: From the AJCC cancer staging manual, V6th